Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2006-07-14
2008-10-14
Lucas, Zachariah (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S274100, C424S278100
Reexamination Certificate
active
07435417
ABSTRACT:
Disclosed is a pharmaceutical composition which comprises a disrupted cell suspension ofMonilia albicansand euglobulin as effective ingredients, wherein the disrupted cell suspension of theMonilia albicansis prepared by culturing theMonilia albicansin a liquid culture medium, centrifuging the resulting culture fluid, recovering the supernatant and disrupting the collected cells, and mixing the supernatant and the cell lysate after inactivation, wherein the culture fluid contains theMonilia albicansof about 1.2×109cfu/ml. Also, the present invention discloses a method of treating animals infected with canine distemper virus or animals with neurological disorders.
REFERENCES:
Definition “euglobulin”, The On-line Medical Dictionary, cancerweb.ncl.ac.uk/omd/ (2003).
Heesen et al., “Cloning of the Mouse Fusin Gene, Homologue to a Human HIV-1 Co-factor,” The Journal of Immunology, vol. 157 No. 12, pp. 5455-5460 (Dec. 1996).
Abelman ,Frayne & Schwab
Lucas Zachariah
LandOfFree
Pharmaceutical composition containing disrupted cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition containing disrupted cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing disrupted cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3997749